Biological Functions of the Genes in the Mammaprint Breast Cancer Profile Reflect the Hallmarks of Cancer

Show other versions (1)

Bibliographic Details
Main Authors:	Annuska M Glas, Paul Roepman, Laura J van’t Veer, Rene Bernards, Femke de Snoo, Sun Tian
Format:	Article
Language:	English
Published:	SAGE Publishing 2010-11-01
Series:	Biomarker Insights
Online Access:	http://www.la-press.com/biological-functions-of-the-genes-in-the-mammaprint-breast-cancer-prof-a2372

Similar Items

Biological Functions of the Genes in the Mammaprint Breast Cancer Profile Reflect the Hallmarks of Cancer
by: Sun Tian, et al.
Published: (2010-01-01)

Prognostic Value of MammaPrint in Invasive Lobular Breast Cancer
by: Inès J. Beumer, et al.
Published: (2016-01-01)

Prognostic Value of MammaPrint® in Invasive Lobular Breast Cancer
by: Inès J. Beumer, et al.
Published: (2016-12-01)

A prognostic gene expression profile that predicts circulating tumor cell presence in breast cancer patients.
by: Timothy J Molloy, et al.
Published: (2012-01-01)

MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial
by: Hatem Soliman, et al.
Published: (2020-01-01)

A gene expression profile for detection of sufficient tumour cells in breast tumour tissue: microarray diagnosis eligibility
by: Witteveen Anke T, et al.
Published: (2009-08-01)

P015 Breast Cancer patient selection for Extended Endocrine Therapy in the IDEAL trial by the 70-gene MammaPrint Test can prevent overtreatment and associated adverse events
by: G.-J. Liefers, et al.
Published: (2023-03-01)

The cost impact of unselective vs selective MammaPrint testing in early-stage breast cancer in Southern Africa
by: Ettienne J. Myburgh, et al.
Published: (2021-10-01)

RE: The cost impact of unselective vs selective MammaPrint testing in early-stage breast cancer in Southern Africa
by: Fabio Postiglione Mansani, et al.
Published: (2022-04-01)

Comparing MammaPrint and BluePrint results between core needle biopsy and surgical resection breast cancer specimens
by: M. Kleijn, et al.
Published: (2021-04-01)

A nomogram for predicting probability of low risk of MammaPrint results in women with clinically high-risk breast cancer
by: Young Joo Lee, et al.
Published: (2021-12-01)

Gene co-expression modules as clinically relevant hallmarks of breast cancer diversity.
by: Denise M Wolf, et al.
Published: (2014-01-01)

Converting a breast cancer microarray signature into a high-throughput diagnostic test
by: Warmoes Marc O, et al.
Published: (2006-10-01)

MammaPrint versus EndoPredict: Poor correlation in disease recurrence risk classification of hormone receptor positive breast cancer.
by: Andreas Bösl, et al.
Published: (2017-01-01)

Hallmarks and Determinants of Oncogenic Translation Revealed by Ribosome Profiling in Models of Breast Cancer
by: Christos Vaklavas, et al.
Published: (2020-02-01)

Validation study of a nomogram for predicting probability of low risk of MammaPrint results in women with clinically high-risk breast cancer
by: Young Sol Hwang, et al.
Published: (2022-12-01)

Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer.
by: Alberto Peláez-García, et al.
Published: (2017-01-01)

Platelets in the tumor microenvironment and their biological effects on cancer hallmarks
by: Lilan Chen, et al.
Published: (2023-03-01)

Invasion and Metastasis as a Central Hallmark of Breast Cancer
by: Trishna Saha, et al.
Published: (2021-08-01)

HMGA2 Supports Cancer Hallmarks in Triple-Negative Breast Cancer
by: Behzad Mansoori, et al.
Published: (2021-10-01)

Allicin and Cancer Hallmarks
by: Wamidh H. Talib, et al.
Published: (2024-03-01)

The Hallmarks of Flavonoids in Cancer
by: Luis Gustavo Saboia Ponte, et al.
Published: (2021-04-01)

Melatonin and Cancer Hallmarks
by: Wamidh H. Talib
Published: (2018-02-01)

The microbiome and the hallmarks of cancer.
by: Laura E Fulbright, et al.
Published: (2017-09-01)

FAP-a and GOLPH3 Are Hallmarks of DCIS Progression to Invasive Breast Cancer
by: Li-Na Yu, et al.
Published: (2019-12-01)

A framework to predict the applicability of Oncotype DX, MammaPrint, and E2F4 gene signatures for improving breast cancer prognostic prediction
by: Kevin Yao, et al.
Published: (2022-02-01)

Physical Exercise and the Hallmarks of Breast Cancer: A Narrative Review
by: Celia García-Chico, et al.
Published: (2023-01-01)

Chromosomal Instability as Enabling Feature and Central Hallmark of Breast Cancer
by: Castellanos G, et al.
Published: (2023-03-01)

Asymmetric Cancer Hallmarks in Breast Tumors on Different Sides of the Body.
by: Emanuel M Campoy, et al.
Published: (2016-01-01)

The gene regulatory network for breast cancer: Integrated regulatory landscape of cancer hallmarks
by: Frank eEmmert-Streib, et al.
Published: (2014-02-01)

P157 MammaPrint 8-year follow up results in patients with early breast cancer from a single-center Italian cohort study
by: E. Fiorino, et al.
Published: (2023-03-01)

Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris
by: Laurence Slembrouck, et al.
Published: (2019-12-01)

CK2 and the Hallmarks of Cancer
by: May-Britt Firnau, et al.
Published: (2022-08-01)

Purinergic Signaling in the Hallmarks of Cancer
by: Anaí del Rocío Campos-Contreras, et al.
Published: (2020-07-01)

Hallmarks of cancer—the new testament
by: Sasi S. Senga, et al.
Published: (2021-01-01)

NTN4 as a prognostic marker and a hallmark for immune infiltration in breast cancer
by: Lili Yi, et al.
Published: (2022-06-01)

Ginsenosides: changing the basic hallmarks of cancer cells to achieve the purpose of treating breast cancer
by: Rui-yuan Jiang, et al.
Published: (2023-09-01)

The PARP Enzyme Family and the Hallmarks of Cancer Part 2: Hallmarks Related to Cancer Host Interactions
by: Máté A. Demény, et al.
Published: (2021-04-01)

P166 Budget impact of MammaPrint® in Patients with primary hormone receptor-positive, HER2-negative and non-metastatic early-stage breast cancer in France
by: D. Zarca, et al.
Published: (2023-03-01)

The PARP Enzyme Family and the Hallmarks of Cancer Part 1. Cell Intrinsic Hallmarks
by: Máté A. Demény, et al.
Published: (2021-04-01)